---
figid: PMC7561725__41467_2020_18973_Fig7_HTML
figtitle: Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote
  cancer progression through AKT activation
organisms:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Gallus gallus
- Bacillus anthracis
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7561725
filename: 41467_2020_18973_Fig7_HTML.jpg
figlink: pmc/articles/PMC7561725/figure/Fig7/
number: F7
caption: In normal cells (e.g. MCF10A cells) the tumour and metastasis suppressor
  TAp63 inhibits the expression of TROLL-2 and TROLL-3, while NOLC1 interacts with
  WDR26 and promotes the accumulation of WDR26 in the nucleus. In cancer cells (e.g.
  CA1D cells), instead, mutant p53 inhibits TAp63, thus allowing for the expression
  of TROLL-2 and TROLL-3. These lncRNAs counteract the interaction between NOLC1 and
  WDR26, while promoting the binding of WDR26 to AKT. As a consequence, the PI3K/AKT
  pathway is activated and can sustain tumour formation and progression.
papertitle: Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote
  cancer progression through AKT activation.
reftext: Marco Napoli, et al. Nat Commun. 2020;11:5156.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9705438
figid_alias: PMC7561725__F7
figtype: Figure
redirect_from: /figures/PMC7561725__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7561725__41467_2020_18973_Fig7_HTML.html
  '@type': Dataset
  description: In normal cells (e.g. MCF10A cells) the tumour and metastasis suppressor
    TAp63 inhibits the expression of TROLL-2 and TROLL-3, while NOLC1 interacts with
    WDR26 and promotes the accumulation of WDR26 in the nucleus. In cancer cells (e.g.
    CA1D cells), instead, mutant p53 inhibits TAp63, thus allowing for the expression
    of TROLL-2 and TROLL-3. These lncRNAs counteract the interaction between NOLC1
    and WDR26, while promoting the binding of WDR26 to AKT. As a consequence, the
    PI3K/AKT pathway is activated and can sustain tumour formation and progression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WDR26
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - NOLC1
  - CG7611
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
---
